-+ 0.00%
-+ 0.00%
-+ 0.00%

Tiziana Life Sciences Launches Phase 2 Trial of Intranasal Foralumab for Early Alzheimer’s Disease

Reuters·12/12/2025 19:10:13

Please log in to view news